FI964959A - Diasyyliglyserolia, fosfolipidiä, polaarista nestettä ja biologisesti aktiivista materiaalia sisältävä lipidipohjainen koostumus - Google Patents

Diasyyliglyserolia, fosfolipidiä, polaarista nestettä ja biologisesti aktiivista materiaalia sisältävä lipidipohjainen koostumus Download PDF

Info

Publication number
FI964959A
FI964959A FI964959A FI964959A FI964959A FI 964959 A FI964959 A FI 964959A FI 964959 A FI964959 A FI 964959A FI 964959 A FI964959 A FI 964959A FI 964959 A FI964959 A FI 964959A
Authority
FI
Finland
Prior art keywords
biologically active
active material
phase
phospholipid
pct
Prior art date
Application number
FI964959A
Other languages
English (en)
Swedish (sv)
Other versions
FI964959A0 (fi
Inventor
Helena Ljusberg-Wahren
Kaore Larsson
Original Assignee
Gs Dev Ab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Gs Dev Ab filed Critical Gs Dev Ab
Publication of FI964959A publication Critical patent/FI964959A/fi
Publication of FI964959A0 publication Critical patent/FI964959A0/fi

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/127—Liposomes
    • A61K9/1274—Non-vesicle bilayer structures, e.g. liquid crystals, tubules, cubic phases, cochleates; Sponge phases
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P23/00—Anaesthetics
    • A61P23/02—Local anaesthetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/10—Antimycotics

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Epidemiology (AREA)
  • Oncology (AREA)
  • Dispersion Chemistry (AREA)
  • Anesthesiology (AREA)
  • Communicable Diseases (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Saccharide Compounds (AREA)
  • Manufacturing Of Micro-Capsules (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
FI964959A 1994-06-15 1996-12-11 Diasyyliglyserolia, fosfolipidiä, polaarista nestettä ja biologisesti aktiivista materiaalia sisältävä lipidipohjainen koostumus FI964959A0 (fi)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
SE9402106A SE518578C2 (sv) 1994-06-15 1994-06-15 Lipidbaserad komposition
PCT/SE1995/000593 WO1995034287A1 (en) 1994-06-15 1995-05-24 Lipid based composition containing diacylglycerol, phospholipid, polar liquid and biologically active material

Publications (2)

Publication Number Publication Date
FI964959A true FI964959A (fi) 1996-12-11
FI964959A0 FI964959A0 (fi) 1996-12-11

Family

ID=20394403

Family Applications (1)

Application Number Title Priority Date Filing Date
FI964959A FI964959A0 (fi) 1994-06-15 1996-12-11 Diasyyliglyserolia, fosfolipidiä, polaarista nestettä ja biologisesti aktiivista materiaalia sisältävä lipidipohjainen koostumus

Country Status (11)

Country Link
US (1) US5807573A (fi)
EP (1) EP0767656B1 (fi)
JP (1) JP3825468B2 (fi)
AT (1) ATE203399T1 (fi)
AU (1) AU2756395A (fi)
CA (1) CA2192190C (fi)
DE (1) DE69521896T2 (fi)
FI (1) FI964959A0 (fi)
NO (1) NO965380L (fi)
SE (1) SE518578C2 (fi)
WO (1) WO1995034287A1 (fi)

Families Citing this family (106)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2726762B1 (fr) * 1994-11-10 1997-01-17 Oreal Composition cosmetique ou dermatologique sous forme d'une dispersion d'une phase huileuse dans une phase aqueuse stabilisee a l'aide de particules de gel cubique et son procede d'obtention
SE510363C2 (sv) * 1996-09-05 1999-05-17 Gs Dev Ab Användning av en flytande kristallin fas för att bestämma fördelningen av en kemisk substans mellan en hydrofob och en hydrofil miljö
SE511313C2 (sv) * 1997-01-13 1999-09-06 Gs Dev Ab Komposition med reglerad frisättning innefattande fettsyraester av diacylglycerol
CA2286052A1 (en) * 1997-04-17 1998-10-29 Lise Sylvest Nielsen A novel bioadhesive drug delivery system based on liquid crystals
NZ503513A (en) * 1997-09-18 2004-12-24 Skyepharma Inc Sustained-release liposomal anesthetic compositions
IL135989A0 (en) 1997-11-14 2001-05-20 Skyepharma Inc Processes for the production of multivesicular liposomes
FR2780644B1 (fr) * 1998-07-03 2001-07-20 Oreal Composition cosmetique ou dermatologique sous forme d'une dispersion d'une phase huileuse et d'une phase aqueuse, stabilisee a l'aide de particules de gel cubique
SE9802528D0 (sv) * 1998-07-13 1998-07-13 Gs Dev Ab Bone tissue restoring composition
SE514908C2 (sv) * 1998-07-13 2001-05-14 Gs Dev Ab Medel för benrekonstruktion
GB9827034D0 (en) * 1998-12-10 1999-02-03 Univ Manchester Delivery formulation
US6761903B2 (en) 1999-06-30 2004-07-13 Lipocine, Inc. Clear oil-containing pharmaceutical compositions containing a therapeutic agent
US6458383B2 (en) 1999-08-17 2002-10-01 Lipocine, Inc. Pharmaceutical dosage form for oral administration of hydrophilic drugs, particularly low molecular weight heparin
GB0001449D0 (en) * 2000-01-21 2000-03-08 Cortendo Ab Compositions
US6800298B1 (en) 2000-05-11 2004-10-05 Clemson University Biological lubricant composition and method of applying lubricant composition
US20020153508A1 (en) * 2000-06-29 2002-10-24 Lynch Matthew Lawrence Cubic liquid crystalline compositions and methods for their preparation
DE10057770A1 (de) * 2000-11-22 2002-05-23 Beiersdorf Ag Hautpflegeprodukte mit einem Gehalt an dispersen Flüssigkristallen, welche kubische Phasen darstellen ,
DE10057769A1 (de) 2000-11-22 2002-05-23 Beiersdorf Ag Haarpflegeprodukte mit einem Gehalt an dispersen Flüssigkristallen, welche kubische Phasen darstellen
US6610322B1 (en) * 2000-12-20 2003-08-26 Brian Charles Keller Self forming, thermodynamically stable liposomes and their applications
US6936187B2 (en) * 2001-02-21 2005-08-30 Matthew Lawrence Lynch Functionalized cubic liquid crystalline phase materials and methods for their preparation and use
US6656385B2 (en) * 2001-02-21 2003-12-02 The Procter & Gamble Company Functionalized cubic liquid crystalline phase materials and methods for their preparation and use
IL158819A0 (en) * 2001-05-31 2004-05-12 Skyepharma Inc Encapsulation of nanosuspensions in liposomes and microspheres
DE10127406A1 (de) * 2001-06-06 2002-12-12 Xzillion Gmbh & Co Kg Verfahren zur elektrophoretischen Trennung von Proben
US20040018237A1 (en) * 2002-05-31 2004-01-29 Perricone Nicholas V. Topical drug delivery using phosphatidylcholine
US8865021B2 (en) 2003-11-07 2014-10-21 Camurus Ab Compositions of lipids and cationic peptides
WO2006075124A1 (en) * 2005-01-14 2006-07-20 Camurus Ab Somatostatin analogue formulations
EP1713446B1 (en) 2004-01-23 2010-12-01 Camurus Ab Ternary non-lamellar lipid compositions
GB0412530D0 (en) * 2004-06-04 2004-07-07 Camurus Ab Formulation
JP5127449B2 (ja) 2004-06-04 2013-01-23 カムルス エービー 流体デポ製剤
US20060127437A1 (en) * 2004-12-13 2006-06-15 Misty Anderson Kennedy Semisolid system and combination semisolid, multiparticulate system for sealing tissues and/or controlling biological fluids
US20070059350A1 (en) * 2004-12-13 2007-03-15 Kennedy John P Agents for controlling biological fluids and methods of use thereof
US8535709B2 (en) * 2004-12-13 2013-09-17 Southeastern Medical Technologies, Llc Agents for controlling biological fluids and methods of use thereof
DE602005026998D1 (de) * 2005-01-14 2011-04-28 Camurus Ab Somatostatin-analog-formulierungen
US9649382B2 (en) 2005-01-14 2017-05-16 Camurus Ab Topical bioadhesive formulations
WO2006075123A1 (en) * 2005-01-14 2006-07-20 Camurus Ab Topical bioadhesive formulations
SI1845942T1 (sl) 2005-01-14 2014-06-30 Camurus Ab Gnrh analogne formulacije
KR101245022B1 (ko) * 2005-01-21 2013-03-19 카무러스 에이비 약제학적 지질 조성물
GB0501364D0 (en) * 2005-01-21 2005-03-02 Camurus Ab Compositions
CA2609810C (en) * 2005-06-06 2012-05-22 Camurus Ab Glp-1 analogue formulations
US20070020228A1 (en) * 2005-07-22 2007-01-25 Williams Terry N Method of using a biosealant device
US20070092462A1 (en) * 2005-10-24 2007-04-26 Julio Gans Russ Cosmetic compositions
CN101309713A (zh) 2005-11-17 2008-11-19 周吉尼克斯股份有限公司 用无针注射递送粘稠制剂
WO2007060174A1 (en) * 2005-11-23 2007-05-31 Nestec S.A. Oil-in-water emulsion for creating new product consistencies
US8268347B1 (en) 2006-10-24 2012-09-18 Aradigm Corporation Dual action, inhaled formulations providing both an immediate and sustained release profile
GB0711656D0 (en) 2007-06-15 2007-07-25 Camurus Ab Formulations
US8333787B2 (en) 2007-12-31 2012-12-18 St. Jude Medical Puerto Rico Llc Vascular closure device having a flowable sealing material
US8568445B2 (en) 2007-08-21 2013-10-29 St. Jude Medical Puerto Rico Llc Extra-vascular sealing device and method
GB0716385D0 (en) 2007-08-22 2007-10-03 Camurus Ab Formulations
EP2052716B1 (en) * 2007-10-24 2014-12-31 Camurus AB Controlled release formulations
US8840640B2 (en) 2007-12-31 2014-09-23 St. Jude Medical Puerto Rico Llc Vascular closure device having an improved plug
ES2527448T3 (es) 2008-04-28 2015-01-23 Zogenix, Inc. Nuevas formulaciones para el tratamiento de la migraña
GB0815435D0 (en) 2008-08-22 2008-10-01 Camurus Ab Formulations
EP2165706A1 (en) 2008-09-18 2010-03-24 BioAlliance Pharma Treating Inflammatory Pain in Mucosa of the Oral Cavity Using Mucosal Prolonged Release Bioadhesive Therapeutic Carriers.
MX2011005076A (es) * 2008-11-14 2011-08-04 Archer Daniels Midland Co Composiciones de organogel y procesos para su produccion.
US11304960B2 (en) 2009-01-08 2022-04-19 Chandrashekar Giliyar Steroidal compositions
WO2011075623A1 (en) 2009-12-18 2011-06-23 Latitude Pharmaceuticals, Inc. One - phase gel compos ition compri s ing phos pholi pids
US9034858B2 (en) 2010-11-30 2015-05-19 Lipocine Inc. High-strength testosterone undecanoate compositions
US9358241B2 (en) 2010-11-30 2016-06-07 Lipocine Inc. High-strength testosterone undecanoate compositions
US20180153904A1 (en) 2010-11-30 2018-06-07 Lipocine Inc. High-strength testosterone undecanoate compositions
US20120148675A1 (en) 2010-12-10 2012-06-14 Basawaraj Chickmath Testosterone undecanoate compositions
WO2012106634A1 (en) 2011-02-03 2012-08-09 Alexion Pharmaceuticals, Inc. Use of an anti-cd200 antibody for prolonging the survival of allografts
WO2012125214A1 (en) 2011-03-17 2012-09-20 Transdermal Biotechnology, Inc. Topical nitric oxide systems and methods of use thereof
KR101494594B1 (ko) 2011-08-30 2015-02-23 주식회사 종근당 약리학적 활성물질의 서방성 지질 초기제제 및 이를 포함하는 약제학적 조성물
JP6081480B2 (ja) 2011-12-05 2017-02-15 カムルス エービー 頑強な徐放性製剤
CA2874367C (en) 2012-05-25 2020-08-18 Camurus Ab Somatostatin receptor agonist formulations
EP3791861A1 (en) 2012-07-26 2021-03-17 Camurus AB Opioid formulations
US8871255B2 (en) 2012-09-19 2014-10-28 Transdermal Biotechnology, Inc. Treatment of skin and soft tissue infection with nitric oxide
US8871257B2 (en) 2012-09-19 2014-10-28 Transdermal Biotechnology, Inc. Prevention and treatment of cardiovascular diseases using systems and methods for transdermal nitric oxide delivery
US8871261B2 (en) 2012-09-19 2014-10-28 Transdermal Biotechnology, Inc. Cancer treatments and compositions for use thereof
US8871262B2 (en) 2012-09-19 2014-10-28 Transdermal Biotechnology, Inc. Compositions and methods for treatment of osteoporosis and other indications
US8871258B2 (en) 2012-09-19 2014-10-28 Transdermal Biotechnology, Inc. Treatment and prevention of learning and memory disorders
US8871256B2 (en) 2012-09-19 2014-10-28 Transdermal Biotechnology, Inc. Methods and systems for treatment of inflammatory diseases with nitric oxide
US8871254B2 (en) 2012-09-19 2014-10-28 Transdermal Biotechnology, Inc. Systems and methods for treatment of acne vulgaris and other conditions with a topical nitric oxide delivery system
US8871259B2 (en) 2012-09-19 2014-10-28 Transdermal Biotechnology, Inc. Techniques and systems for treatment of neuropathic pain and other indications
US8871260B2 (en) 2012-09-19 2014-10-28 Transdermal Biotechnology, Inc. Methods and compositions for muscular and neuromuscular diseases
KR101586790B1 (ko) * 2012-12-28 2016-01-19 주식회사 종근당 음이온성 약리학적 활성물질의 서방성 지질 초기제제 및 이를 포함하는 약제학적 조성물
KR101586791B1 (ko) 2012-12-28 2016-01-19 주식회사 종근당 ＧｎＲＨ 유도체의 서방성 지질 초기제제 및 이를 포함하는 약제학적 조성물
US9241899B2 (en) 2013-03-13 2016-01-26 Transdermal Biotechnology, Inc. Topical systems and methods for treating sexual dysfunction
US9314422B2 (en) 2013-03-13 2016-04-19 Transdermal Biotechnology, Inc. Peptide systems and methods for metabolic conditions
US9724419B2 (en) 2013-03-13 2017-08-08 Transdermal Biotechnology, Inc. Peptide systems and methods for metabolic conditions
US9387159B2 (en) 2013-03-13 2016-07-12 Transdermal Biotechnology, Inc. Treatment of skin, including aging skin, to improve appearance
US9393265B2 (en) 2013-03-13 2016-07-19 Transdermal Biotechnology, Inc. Wound healing using topical systems and methods
US9295647B2 (en) 2013-03-13 2016-03-29 Transdermal Biotechnology, Inc. Systems and methods for delivery of peptides
US9339457B2 (en) 2013-03-13 2016-05-17 Transdermal Biotechnology, Inc. Cardiovascular disease treatment and prevention
US9320706B2 (en) 2013-03-13 2016-04-26 Transdermal Biotechnology, Inc. Immune modulation using peptides and other compositions
US9849160B2 (en) 2013-03-13 2017-12-26 Transdermal Biotechnology, Inc. Methods and systems for treating or preventing cancer
US9393264B2 (en) 2013-03-13 2016-07-19 Transdermal Biotechnology, Inc. Immune modulation using peptides and other compositions
US9687520B2 (en) 2013-03-13 2017-06-27 Transdermal Biotechnology, Inc. Memory or learning improvement using peptide and other compositions
US20140271731A1 (en) 2013-03-13 2014-09-18 Transdermal Biotechnology, Inc. Cardiovascular disease treatment and prevention
US9750787B2 (en) 2013-03-13 2017-09-05 Transdermal Biotechnology, Inc. Memory or learning improvement using peptide and other compositions
US9320758B2 (en) 2013-03-13 2016-04-26 Transdermal Biotechnology, Inc. Brain and neural treatments comprising peptides and other compositions
US9314433B2 (en) 2013-03-13 2016-04-19 Transdermal Biotechnology, Inc. Methods and systems for treating or preventing cancer
US9314417B2 (en) 2013-03-13 2016-04-19 Transdermal Biotechnology, Inc. Treatment of skin, including aging skin, to improve appearance
US9295637B2 (en) 2013-03-13 2016-03-29 Transdermal Biotechnology, Inc. Compositions and methods for affecting mood states
US9295636B2 (en) 2013-03-13 2016-03-29 Transdermal Biotechnology, Inc. Wound healing using topical systems and methods
US20140271938A1 (en) 2013-03-13 2014-09-18 Transdermal Biotechnology, Inc. Systems and methods for delivery of peptides
US9314423B2 (en) 2013-03-13 2016-04-19 Transdermal Biotechnology, Inc. Hair treatment systems and methods using peptides and other compositions
US20140271937A1 (en) 2013-03-13 2014-09-18 Transdermal Biotechnology, Inc. Brain and neural treatments comprising peptides and other compositions
WO2016033556A1 (en) 2014-08-28 2016-03-03 Lipocine Inc. BIOAVAILABLE SOLID STATE (17-β)-HYDROXY-4-ANDROSTEN-3-ONE ESTERS
WO2016033549A2 (en) 2014-08-28 2016-03-03 Lipocine Inc. (17-ß)-3-OXOANDROST-4-EN-17-YL TRIDECANOATE COMPOSITIONS AND METHODS OF THEIR PREPARATION AND USE
US20180147215A1 (en) 2016-11-28 2018-05-31 Lipocine Inc. Oral testosterone undecanoate therapy
SG11202000629QA (en) 2017-07-27 2020-02-27 Allergan Inc Prostacyclin receptor agonists for reduction of body fat
WO2020059543A1 (ja) * 2018-09-20 2020-03-26 富士フイルム株式会社 生体材料
US11278494B1 (en) 2021-01-22 2022-03-22 Pacira Pharmaceuticals, Inc. Manufacturing of bupivacaine multivesicular liposomes
US11033495B1 (en) 2021-01-22 2021-06-15 Pacira Pharmaceuticals, Inc. Manufacturing of bupivacaine multivesicular liposomes
US11357727B1 (en) 2021-01-22 2022-06-14 Pacira Pharmaceuticals, Inc. Manufacturing of bupivacaine multivesicular liposomes
EP4378452A1 (en) * 2021-07-27 2024-06-05 Farnex Incorporated Non-lamellar liquid crystal-forming composition and use thereof

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2907460A1 (de) * 1978-03-07 1979-09-13 Sandoz Ag Neue resorbierbare galenische kompositionen
SE8206744D0 (sv) * 1982-11-26 1982-11-26 Fluidcarbon International Ab Preparat for kontrollerad avgivning av substanser
SE457693B (sv) * 1986-07-01 1989-01-23 Drilletten Ab Komposition med reglerad frigoering vari ett biologiskt material aer loest eller dispergerat i en l2-fas
US5196201A (en) * 1989-10-20 1993-03-23 Bioapatite Ab Implant material composition, preparation thereof as well as uses thereof and implant product obtainable therefrom
US5143934A (en) * 1990-11-21 1992-09-01 A/S Dumex (Dumex Ltd.) Method and composition for controlled delivery of biologically active agents
US5262164A (en) * 1989-11-17 1993-11-16 The Procter & Gamble Company Sustained release compositions for treating periodontal disease
US5164191A (en) * 1991-02-12 1992-11-17 Micro Vesicular Systems, Inc. Lipid vesicles having an alkyd as a wall-forming material
PT100502A (pt) * 1991-05-20 1993-08-31 Alza Corp Composicoes farmaceuticas para aumentar a capacidade de permeacao na pele utilizando monolinoleato de glicerol

Also Published As

Publication number Publication date
NO965380D0 (no) 1996-12-13
JP3825468B2 (ja) 2006-09-27
NO965380L (no) 1996-12-13
EP0767656A1 (en) 1997-04-16
CA2192190A1 (en) 1995-12-21
EP0767656B1 (en) 2001-07-25
AU2756395A (en) 1996-01-05
US5807573A (en) 1998-09-15
ATE203399T1 (de) 2001-08-15
SE9402106D0 (sv) 1994-06-15
SE9402106L (sv) 1995-12-16
DE69521896D1 (de) 2001-08-30
SE518578C2 (sv) 2002-10-29
FI964959A0 (fi) 1996-12-11
WO1995034287A1 (en) 1995-12-21
CA2192190C (en) 2004-09-21
DE69521896T2 (de) 2001-11-22
JPH10504532A (ja) 1998-05-06

Similar Documents

Publication Publication Date Title
FI964959A (fi) Diasyyliglyserolia, fosfolipidiä, polaarista nestettä ja biologisesti aktiivista materiaalia sisältävä lipidipohjainen koostumus
NO843023L (no) Fremgagsmaate for fremstilling av preparater med styrt frigivelse for biologisk aktive materialer og resulterende blandinger
ZA852168B (en) Galenic form for oral administration and its method of preparation by lyophilization of an oil-in-water emulsion
ES2529167T3 (es) Método para utilizar lípidos neutros para modificar la liberación in vivo desde liposomas multivesiculares
ES478056A1 (es) Procedimiento de fabricacion de capsulas lipidicas que con- tienen uno o varios materiales biologicamente activos.
HK1008774A1 (en) A composition comprising an active agent dissolved in a glass-forming carrier and a process for the preparation thereof
SE8602931D0 (sv) A controlled-release composition
BR9912975A (pt) Composto e composições para liberação de agentes ativos, método para sua obtenção e seu uso
BR8007670A (pt) Dispersoes de copolimeros em compostos polifuncionais,tendo uma serie de hidrogenios ativos,metodo para fazer as dispersoes de copolimeros e uma composicao de poliuretana preparada
ZA200005915B (en) Pharmaceutical compositions capable of being gelled.
CL2004001127A1 (es) Compuestos derivados de nitrocompuestos; procedimiento de preparacion de dichos compuestos; composicion insecticida que los contiene; procedimiento para preparar composiciones insecticidas; metodo para combatir insectos daninos.
TR199902025T2 (xx) Suda ileri derecede ��z�nmez olan bir etken maddeyi hapseden liyofilize lipozomlar i�eren farmas�tik preparasyon ve bu preparasyonu haz�rlamak i�in i�lem.
DK0557825T3 (da) Bade- og bruse-tilsætninger med vesikeldannende egenskaber, deres fremstilling og anvendelse
PT76919A (en) Process for preparing pharmaceutical mixture compositions with controlled release of active substance
ES2042437T1 (es) Procedimiento de preparacion de una lipoproteina modificaa por incorporacion de una substancia activa lipofila.
AU1073688A (en) Phospholipid delivery vehicle for aqueous-insoluble active ingredients
ES2078510T3 (es) Dispersion acuosa de vesiculas de fosfolipidos, procedimiento para su fabricacion y su uso.
DE59914774D1 (de) Verfahren zur herstellung von liposomalen wirkstoffformulierungen
ZA987480B (en) Process for preparing contrast agents.
HUT36985A (en) Herbicides containing diphenyl-ethers as active ingredient and method for producing active ingredients
AU4372899A (en) Difluoroalkencarboxanilides and pesticidal compositions
IL72595A (en) Compositions for controlling insects,and members of the order acarina,which compositions contain,as active ingredients,2-(-indolinyl-methyl)-imidazolines or salts thereof,some novel compounds of this type and process for their preparation